acarix Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares November 18, 2024 22 May 2023 Acarix raises approximately SEK 22 million through exercise of warrants and resolves on a directed share issue In December 2022, Acarix AB (publ) (“Acarix” or the “Company”) carried out a rights issue of shares and warrant... Continue reading
acarix Corporate Action, IR, Issuance, Listing Regulation, News, Regulatory, Shares, Swedish November 18, 2024 22 May 2023 Acarix tillförs cirka 22 MSEK genom utnyttjandet av teckningsoptioner och beslutar om riktad nyemission Acarix AB (publ) (“Acarix” eller “Bolaget”) genomförde under december 2022 en företrädesemission... Continue reading
acarix Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM November 18, 2024 11 May 2023 Announcement from Acarix’s annual general meeting The annual general meeting 2023 ("AGM") of Acarix AB ("Acarix" or the "Company") was held today on 11 May 2023 in Stockholm and the fol... Continue reading
acarix Corporate Information, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM, Swedish November 18, 2024 11 May 2023 Kommuniké från årsstämman i Acarix Årsstämman 2023 i Acarix AB ("Acarix" eller "Bolaget") hölls idag den 11 maj 2023 i Stockholm varvid aktieägarna f... Continue reading
acarix English, Interim, IR, Listing Regulation, News, Q1, Regulatory, Report November 18, 2024 11 May 2023 Acarix AB (publ) publishes Interim Report, January – March 2023 2023 is off to a good startIn the first quarter of 2023 our strategy delivered important results with a breakthrough order from the lar... Continue reading
acarix Interim, IR, Listing Regulation, News, Q1, Regulatory, Report, Swedish November 18, 2024 11 May 2023 Acarix AB (publ) publicerar delårsrapport, januari – mars 2023 2023 har börjat braUnder första kvartalet 2023 levererade vi viktiga delresultat med en genombrottsorder från den st&ou... Continue reading
acarix Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory November 18, 2024 02 May 2023 The exercise period for Acarix warrants of series 2022:U begins today In December 2022, Acarix AB (publ) (“Acarix” or the “Company”) carried out a rights issue of shares and warrant... Continue reading
acarix Corporate Information, IR, Listing Regulation, News, Other Corporate Information, Regulatory, Swedish November 18, 2024 02 May 2023 Idag inleds nyttjandeperioden för Acarix teckningsoptioner av serie 2022:U Acarix AB (publ) (“Acarix” eller “Bolaget”) genomförde under december 2022 en företrädesemission... Continue reading
acarix Annual, English, IR, Listing Regulation, News, Regulatory, Report November 18, 2024 20 Apr 2023 Acarix AB’s Annual Report 2022 Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces that the Annual Report for 2022 is available as a pdf on... Continue reading
acarix Annual, IR, Listing Regulation, News, Regulatory, Report, Swedish November 18, 2024 20 Apr 2023 Acarix AB’s Årsredovisning 2022 Acarix, ledare inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag att årsredovisning för 2022 finns tillgä... Continue reading
acarix Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory November 18, 2024 11 Apr 2023 Notice of Annual General Meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the annual general meeting to be held on T... Continue reading
acarix Corporate Information, General meeting, IR, Listing Regulation, News, Notice, Regulatory, Swedish November 18, 2024 11 Apr 2023 Kallelse till årsstämma i Acarix AB Aktieägarna i Acarix AB, org.nr 559009-0667, ("Bolaget") kallas härmed till årsstämma torsdagen den 11 maj 2023 kl... Continue reading